US FDA Proposes New ‘Inter-Pandemic’ Pathway For Updating Flu Vaccines

The threat of a highly pathogenic avian influenza pandemic spurred the FDA to have its vaccine advisory committee comment on a new process to update licensed prototype pandemic flu vaccines.